Clinical Trials
3 trialsNCT01540071 2021-05-14
Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer
Io Therapeutics
Phase 2 Completed
NCT00630760 2014-05-21
Oral NRX 194204 in Patients With Refractory Malignancies
University of Southern California
Phase 1 Terminated
NCT00964132 2009-09-03
Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
NuRx Pharmaceuticals, Inc.
Phase 2 Unknown